Skip Navigation


Mutagenesis Advance Access originally published online on October 18, 2007
Mutagenesis 2007 22(6):417-423; doi:10.1093/mutage/gem038
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
22/6/417    most recent
gem038v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Cardellino, U.
Right arrow Articles by Inga, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cardellino, U.
Right arrow Articles by Inga, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Author 2007. Published by Oxford University Press on behalf of the UK Environmental Mutagen Society. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org.

Transcriptional properties of feline p53 and its tumour-associated mutants: a yeast-based approach

Umberto Cardellino{dagger}, Yari Ciribilli1,{dagger}, Virginia Andreotti1,{dagger}, Paola Modesto, Paola Menichini1, Gilberto Fronza1, Claudio Pellegrino and Alberto Inga1,*

Istituto Zooprofilattico Sperimentale del Piemonte Liguria e Valle d'Aosta, Genoa, Italy 1Unit of Molecular Mutagenesis, National Institute for Cancer Research, IST, Largo R. Benzi X, 16132 Genoa, Italy

Mutations at the tumour suppressor gene TP53 are associated with nearly half of human cancers, but they appear to be rare (~10%) in feline neoplasms. The reasons for this difference are presently unclear but might be related to evolutionary divergence of p53 functions. To begin exploring this issue, we developed a yeast-based functional assay to measure the transcriptional ability of wild-type (wt) or mutant feline p53 (fe_p53) in comparison with human or murine p53 (hu_p53, mo_p53). fe_p53 cDNA was cloned and expressed in a panel of yeast reporter strains engineered to contain the ADE2 or the luciferase gene under p53 control via different p53 response elements. We established that wt fe_, hu_ and mo_p53 can act as transcription factors in yeast with overlapping DNA sequence specificities. Random mutagenesis and phenotypic evaluation of fe_ and hu_p53 cDNAs was also performed, revealing equal susceptibility to deleterious mutations. Five tumour-associated fe_p53 mutants exhibited a similar impact on the transactivation capacity (partial or complete loss) compared to the corresponding hu_p53 mutants. Given the high conservation of the intrinsic functional properties of fe_p53, further studies will be needed to clarify the role of p53 in feline carcinogenetic pathways.

* To whom correspondence should be addressed. Tel:+39 010 5737225; Fax: +39 010 5737237; Email: alberto.inga{at}istge.it


{dagger} These authors contributed equally to this work.

Received on June 20, 2007; revised on August 28, 2007; accepted on August 28, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.